Particle.news
Download on the App Store

First Patient to Receive Pig Then Human Kidney Is Recovering at Home

His case is guiding immunosuppression plans for upcoming FDA-cleared porcine kidney trials.

Overview

  • Tim Andrews, 67, received a deceased-donor human kidney at Massachusetts General Hospital on Tuesday after previously living with a genetically modified pig kidney.
  • He was discharged Friday and is recovering at home in New Hampshire, becoming the first known person to receive a pig kidney and later a human kidney.
  • The pig kidney functioned for a record 271 days before slow rejection led to its removal in October and a return to dialysis.
  • Biopsies and case data point to low-level rejection and irreversible filter damage, and researchers say those findings are helping them adjust suppression regimens.
  • Mass General Brigham and eGenesis report FDA clearance for the first porcine-kidney clinical trial, enabling multi-center enrollment of more than 30 patients, while Andrews' current immunosuppression is about one-third of what he took with the pig graft.